K-V Pharmaceutical Co — Form D
K-V Pharmaceutical Co of Chesterfield, MO, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-25. The offering totals $260.9M, of which $260.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-09-25
- Form: D
- Accession: 0000057055-13-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $260.9M
- Amount sold: $260.9M
- Investors: 28
- Date of first sale: 2013-06-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-203543
Issuer
- Name: K-V Pharmaceutical Co
- CIK: 0000057055
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 16640 Chesterfield Grove Road, Chesterfield, MO, 63005
- Phone: 3146456600
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Gregory J Divis | Director | Chesterfield, MO |
| Eric J Haron | Director | Chesterfield, MO |
| Joe J McGinnis | Director | Chesterfield, MO |
| Steve J Nielson | Director | Chesterfield, MO |
| Jonathan J Siegel | Director | Chesterfield, MO |
| Patrick J Christmas | Executive Officer | Chesterfield, MO |
| Gregory J Divis | Executive Officer | Chesterfield, MO |
| Thomas S McHugh | Executive Officer | Chesterfield, MO |
| Robert E Baldini | Director | Madison, NJ |
| Gregory J Divis, Jr. | Executive Officer | St. Louis, MO |
| Ana I Stancic | Director | Hackensack, NJ |
| David D Sidransky | Director | Bridgeton, MO |
| Mark A Dow | Director | Bridgeton, MO |
| David S Hermelin | Director | Bridgeton, MO |
| Joseph D Lehrer | Director | Bridgeton, MO |
| Gregory S Bentley | Director | Bridgeton, MO |
| Gregory S Bentley | Executive Officer | Bridgeton, MO |
Other filings by this issuer (4)
More